The purpose of this study is to evaluate the reduction of craving after administration of V0018 1.5 mg compared to placebo in healthy moderately dependent smokers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
30
Unnamed facility
Gières, France
Questionnaire for Smoking Urges Brief (QSU-Brief) (10 items)
Change from study baseline to 15 minutes after treatment intake for the QSU-brief total score and demonstrate any earlier effect.
Time frame: 15 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.